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Kawamura M Jr, Ruskin DN, Masino SA. Adenosine A1 receptor-mediated protection of mouse hippocampal synaptic transmission
against oxygen and/or glucose deprivation: a comparative study. J
Neurophysiol 122: 721–728, 2019. First published June 26, 2019;
doi:10.1152/jn.00813.2018.—Adenosine receptors are widely expressed in the brain, and adenosine is a key bioactive substance for
neuroprotection. In this article, we clarify systematically the role of
adenosine A1 receptors during a range of timescales and conditions
when a significant amount of adenosine is released. Using acute
hippocampal slices obtained from mice that were wild type or null
mutant for the adenosine A1 receptor, we quantified and characterized
the impact of varying durations of experimental ischemia, hypoxia,
and hypoglycemia on synaptic transmission in the CA1 subregion. In
normal tissue, these three stressors rapidly and markedly reduced
synaptic transmission, and only treatment of sufficient duration led to
incomplete recovery. In contrast, inactivation of adenosine A1 receptors delayed and/or lessened the reduction in synaptic transmission
during all three stressors and reduced the magnitude of the recovery
significantly. We reproduced the responses to hypoxia and hypoglycemia by applying an adenosine A1 receptor antagonist, validating the
clear effects of genetic receptor inactivation on synaptic transmission.
We found activation of adenosine A1 receptor inhibited hippocampal
synaptic transmission during the acute phase of ischemia, hypoxia, or
hypoglycemia and caused the recovery from synaptic impairment
after these three stressors using genetic mutant. These studies quantify
the neuroprotective role of the adenosine A1 receptor during a variety
of metabolic stresses within the same recording system.
NEW & NOTEWORTHY Deprivation of oxygen and/or glucose
causes a rapid adenosine A1 receptor-mediated decrease in synaptic transmission in mouse hippocampus. We quantified adenosine
A1 receptor-mediated inhibition during and synaptic recovery after
ischemia, hypoxia, and hypoglycemia of varying durations using a
genetic mutant and confirmed these findings using pharmacology.
Overall, using the same recording conditions, we found the acute
response and the neuroprotective ability of the adenosine A1
receptor depended on the type and duration of deprivation event.
acute hippocampal slices; adenosine A1 receptors; field recording;
metabolic stress; synaptic transmission

INTRODUCTION

Adenosine is known as a neuromodulator (Dunwiddie and
Masino 2001), regulating synaptic transmission and membrane
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potential in neurons (Dunwiddie et al. 1997; Masino et al.
2002) and calcium dynamics in glial cells (Kawamura and
Kawamura 2011; Stevens et al. 2002). These acute effects of
adenosine are caused by activation of cell surface receptors,
and adenosine is known to exist in the extracellular space
tonically (Dunwiddie and Hoffer 1980). Tonic levels are maintained by two pathways: breakdown from extracellular ATP
(released by a variety of mechanisms; Kawamura and Ruskin
2012) and direct release from equilibrative nucleoside transporters in postsynaptic neurons (Lovatt et al. 2012) or presynaptic terminals (Cunha et al. 1996). It has recently been
recognized that adenosine can also induce changes in DNA
methylation (Williams-Karnesky et al. 2013). Therefore, beyond dynamic ongoing effects, major transformative functional
effects of adenosine might result from its increased concentration.
A range of physiological/pathophysiological situations are
known to increase extracellular adenosine (Masino et al. 2009),
including ischemia (Fowler 1990; Frenguelli et al. 2007; Pearson et al. 2006), hypoxia (Dale et al. 2000; Fowler 1993),
hypoglycemia (Fowler 1993; Zhu and Krnjević 1993), hypercapnia (Dulla et al. 2005), increased temperature (Masino et al.
2001), neuronal activity (Lovatt et al. 2012), electrical stimulation (Mitchell et al. 1993), and ketone body-based metabolism (Kawamura et al. 2014). Most of these situations represent
shifts in metabolism or a metabolic stress; ketone body-based
metabolism is often coupled with reduced glucose levels. As a
general principle, altered brain metabolism is thought to be one
of the modulators of extracellular adenosine (Latini and Pedata
2001).
Adenosine receptors have four subtypes expressed functionally in mammalian central nervous system (CNS): A1, A2A,
A2B, and A3 (Dunwiddie and Masino 2001; Fredholm et al.
2000). Adenosine A1 receptors (A1Rs) in particular are distributed widely and known to inhibit synaptic transmission by
suppressing influx into presynaptic voltage-dependent calcium
channels in synaptic terminals (Gundlfinger et al. 2007; Wu
and Saggau 1994), hyperpolarizing neuronal membrane potential by opening potassium channels (Haas and Greene 1984;
Kawamura et al. 2010), and inhibiting N-methyl-D-aspartate
(NMDA) receptors in postsynaptic neurons (de Mendonça et
al. 1995). On the other hand, A2ARs are reported to facilitate
synaptic transmission (Lopes et al. 2002) by increasing calcium influx via presynaptic voltage-dependent calcium chan-
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nels (Gonçalves et al. 1997), depolarizing neuronal membrane
potential (Chamberlain et al. 2013; Li and Henry 1998), and
enhancing NMDA receptors in postsynaptic neurons (Rebola et
al. 2008; Scianni et al. 2013; Mouro et al. 2018). Thus
increased extracellular adenosine caused by metabolic changes
can activate A1Rs to suppress neuronal activity and A2ARs to
facilitate neuronal activity. Activation of A1R and blockade of
A2AR are neuroprotective against acute stresses such as stroke,
hypoxic encephalopathy, and hypoglycemia (Cunha 2016,
2005; Fredholm 1997, 2007; Pedata et al. 2016).
In the present study, we used acute hippocampal slices from
wild-type and adenosine A1 receptor knockout (A1KO) mice to
examine systematically the role of the A1R during metabolic
stresses where large amounts of adenosine are known to be
released. Previous work has shown that the A1KO mouse
exhibits a complete loss of A1Rs in all brain regions, and
synaptic transmission in the hippocampus does not respond to
exogenous or elevated endogenous adenosine (Johansson et al.
2001). A1KO mice have normal physiology in terms of body
weight, heart rate, blood pressure, and body temperature but
show thermal hyperalgesia, increased anxiety, and increased
aggressiveness (Giménez-Llort et al. 2002; Johansson et al.
2001). A1KO mice also have electrographic hippocampal seizures (Masino et al. 2011). During extracellular recordings
from hippocampal slices obtained from mice that were wild
type or null mutant for the A1R, we quantified and characterized the consequences of varying periods of ischemia (low
oxygen and low glucose), hypoxia (low oxygen), and hypoglycemia (low glucose) to elucidate systematically the protective effects afforded A1Rs under these conditions.
MATERIALS AND METHODS

Slice preparation. All experiments were performed in accordance
with Public Health Service Policy as defined in the Institute for
Laboratory Animal Research Guide for the Care and Use of Laboratory Animals and approved by Trinity College, and with the Guidelines for the Proper Conduct of Animal Experiments of the Science
Council of Japan (2006) and approved by the Institutional Animal
Care and Use Committee of the Jikei University. C57BL/6 mice (wild
type or lacking adenosine A1 receptors; Johansson et al. 2001) aged 4
–7 wk, of either sex, were anesthetized with isoflurane and
decapitated.
Standard slice preparation and recording conditions were employed, similarly to our previous studies (Johansson et al. 2001;
Masino et al. 2002). Briefly, three to six coronal slices of dorsal
hippocampus of 400-m thickness were made from each brain in
ice-cold artificial cerebrospinal fluid (aCSF) containing (in mM) 126
NaCl, 3 KCl, 1.5 MgCl2, 2.4 CaCl2, 1.2 NaH2PO4, 11 glucose, and 26
NaHCO3 (osmolarity 320 mosM, pH 7.4 when saturated with 95%
O2 ⫹ 5% CO2) with a vibrating slice cutter (series 1000, Vibratome,
St. Louis, MO; or PRO 7, Dosaka, Kyoto, Japan). The slices were
incubated in aCSF saturated with 95% O2 ⫹ 5% CO2 for at least 60
min at room temperature until the recording. The slice was placed on
a nylon net in the recording chamber and submerged in and continuously superfused with aCSF at a flow rate of 2 ml/min at 32 ⫾ 1°C.
The temperature was controlled automatically at ~32°C and adjusted
manually if there was any drift throughout recordings. If the temperature shifted over 1°C from 32°C, the recording was removed from
data. Our nylon net chamber is able to superfuse both the upper and
under sides of surfaces of the slices; a similar type of dual-superfusion
chamber is known to enhance diffusional oxygen supply into the
slices (Hájos et al. 2009; Ivanov and Zilberter 2011).

We applied four different experimental metabolic stress conditions:
1) experimental ischemia (oxygen-glucose deprivation), achieved by
removing 11 mM glucose in the aCSF and replacing it with 11 mM
sucrose and also simultaneously changing from 95% O2 ⫹ 5% CO2 to
95% N2 ⫹ 5% CO2; 2) experimental hypoxia, by changing to
saturated aCSF with 95% N2 ⫹ 5% CO2; 3) experimental hypoglycemia, by removing 11 mM glucose in the aCSF and adding the same
concentration of sucrose; and 4) reduced (3 mM) glucose with
hypoxia, by reducing 11 mM glucose to 3 mM (while including 8 mM
sucrose in the aCSF) and simultaneously changing to 95% N2 ⫹ 5%
CO2. Removing oxygen from the aCSF greatly decreases oxygen
supply but cannot cause complete anoxia in the recording slices
because the dual-superfusion chamber is open to the atmosphere
(Hájos et al. 2009). Therefore, we use the term “hypoxia” in the
current report.
Extracellular recordings. Field excitatory postsynaptic potentials
(fEPSP) were recorded similarly to our previous studies (Johansson et
al. 2001; Masino et al. 2002). Briefly, medium wall (1.5 mm) capillary
filament glass was pulled on a Sutter P-97 micropipette puller (Novato, CA), giving electrode resistances of 8 –12 M⍀. The recording
electrode filled with 3 M NaCl was placed in the stratum radiatum of
CA1 region. A twisted bipolar insulated tungsten electrode was placed
as stimulation electrode in the stratum radiatum; stimuli were delivered at 15- or 30-s intervals. Pulse duration was 100 s, and the
intensity was adjusted such that the amplitude of evoked fEPSP was
half of the maximal response.
Drugs and their application. The adenosine receptor antagonist
8-cyclopentyltheophylline (CPT) was dissolved in aCSF at 100 times
the desired final concentration and applied via syringe pump upstream
in the superfusion line to reach final concentration before reaching the
slice chamber (Masino et al. 1999). In all figures, the point indicated
as the onset of changing condition is the calculated time when the
solution first begins to mix into the volume of the slice chamber.
Data and statistical analysis. All electrophysiological responses
were recorded via an alternating current amplifier (model 3000; A-M
Systems, Carlsborg, WA) and filtered at 1 kHz. Data were digitized
(16-channel analog-to digital board; National Instruments Japan, Tokyo, Japan) at a rate of 4 kHz and analyzed off-line using Igor Pro 5
(WaveMetrics, Lake Oswego, OR). All amplitude data are normalized
by baseline (%baseline) and expressed as means ⫾ SE, similarly to
our previous study (Kawamura et al. 2014). Amplitudes of fEPSPs
were compared with the use of unpaired t-test for two groups or
one-way ANOVA with Bonferroni correction for three groups using
GraphPad InStat 3.10 (GraphPad Software, La Jolla, CA). Probability
(P) ⬍ 0.05 was considered significant. The number of experiments (n)
in figures refers to the recorded slices.
RESULTS

We recorded fEPSPs using extracellular recordings in 117
hippocampal slices from wild-type (WT) mice and 66 hippocampal slices from A1KO mice under four different conditions: 1) ischemia, 2) hypoxia, 3) hypoglycemia, and 4) reduced glucose with hypoxia.
Irreversible synaptic loss with experimental ischemia. We
first tested the effects of experimental ischemia (duration
ranging from 5 to 30 min) on excitatory synaptic transmission
in WT hippocampal slices. Longer experimental ischemia
(10 –30 min) caused three phases of synaptic changes: 1) rapid
decrease in fEPSP amplitude, 2) transient increase of fEPSP
amplitude, and 3) disappearance of fEPSP (Fig. 1A). The
transient increase in fEPSP amplitude (Fig. 1A, arrowhead) is
termed a “transient reappearance” and thought to be caused by
synchronized neuronal hyperexcitability and spreading depression (Madry et al. 2010; Pugliese et al. 2003). After transient
reappearance, long-term ischemia abolished the fEPSP sud-
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Fig. 1. Experimental ischemia-induced field excitatory postsynaptic potential
(fEPSP) modulation. A, left: change in fEPSP amplitudes with 5-, 10-, or
30-min experimental ischemia [oxygen and glucose deprivation (OGD): N2 ⫹
0 mM glucose] in hippocampal slices from wild-type (WT) mice. Averages of
fEPSP amplitudes are shown at each time point (2 min), and vertical bars are
SE. Transient reappearances are shown at arrowheads in 10-min (black) and
30-min (gray) OGD. Right: summary of averages of fEPSP amplitudes at 1–2
min before ischemia (before), during ischemia (OGD), and 15–20 min after
ischemia (recovery). NS, not significantly different; *P ⬍ 0.05; **P ⬍ 0.01
(1-way ANOVA with post hoc test). B1: effects of 5-min OGD (N2 ⫹ 0 mM
glucose) in slices from WT mice or adenosine A1 receptor knockout (A1KO)
mice. Data shown from WT mice are the same as 5-min OGD in A. **P ⬍ 0.01
(unpaired t-test). B2: effects of 10-min OGD (N2 ⫹ 0 mM glucose) in slices
from WT or A1KO mice. Data shown from WT mice are the same as 10-min
OGD in A. *P ⬍ 0.05; **P ⬍ 0.01 (unpaired t-test).

denly and irreversibly, an effect thought to mimic a core
region of brain impairment after stroke (Pugliese et al.
2003). This permanent and complete loss of synaptic transmission was only caused by long-term (30 min) experimental ischemia. Short-term ischemia (5 min) inhibited the
amplitude of fEPSP rapidly, but this inhibition reversed
completely after reperfusion of normal aCSF (Fig. 1A). A
10-min duration of ischemia caused a rapid inhibition of
fEPSP and transient reappearance similar to that in 30-min
ischemia, but the amplitude of fEPSP recovered partially
and significantly after reperfusion of normal aCSF; there
was not a complete and irreversible loss as was seen
consistently with 30-min ischemia (Fig. 1A).

723

In slices obtained from A1KO mice, the rapid inhibition of
fEPSP with 5-min ischemia did not occur (Fig. 1B1), suggesting that this inhibition is reversible and caused by activation of
A1Rs. Similarly, with 10-min ischemia, the fEPSP was not
rapidly inhibited in slices from A1KO mice: it was suppressed
with delayed onset and finally lost (Fig. 1B2). The significant
partial recovery in the slices from WT mice after 10-min
ischemia did not occur in the slices from A1KO mice. Consistent with 10-min ischemia, more long-term ischemia (⬎20
min) in A1KO mice also caused a delayed onset of fEPSP
inhibition and irreversible loss of synaptic transmission (data
not shown).
Together, these results indicate at least two things: first, the
quick-onset fEPSP suppression during ischemia depends on
A1Rs, although fEPSP suppression after ischemia of a sufficient duration (⬎10 min) occurs even in the absence of A1Rs.
Second, activation of A1Rs is essential for fEPSP recovery
after ischemia. This A1R -induced recovery is only effective
within a limited duration of experimental ischemia: more
prolonged ischemia (⬎10 min) caused irreversible synaptic
loss even in the WT mice (Fig. 1A).
Modest synaptic loss of fEPSP with experimental hypoxia or
hypoglycemia. We next recorded changes in fEPSP amplitude
after experimental hypoxia (by removing oxygen) or experimental hypoglycemia (by removing glucose). All durations of
hypoxia (5, 10, and 30 min) induced rapid and complete
inhibition of fEPSP amplitude, but in all cases the inhibition
was fully reversible (Fig. 2A), unlike when glucose and oxygen
were both removed (Fig. 1A). The rapid inhibition with 10-min
hypoxia was not seen in slices from A1KO mice (Fig. 2B1),
suggesting that hypoxia-induced reversible fEPSP inhibition is
caused by activation of A1Rs. Interestingly, a very long period
of hypoxia (60 min) in the A1KO mice induced a partial but
significant suppression of fEPSP amplitude (Fig. 2B2) that was
long lasting: it continued over 30 min after reperfusion of
normal oxygenated aCSF (data not shown). This suppression
was not caused by any nonspecific effect of the deletion of
functional A1Rs: a similar modest suppression was shown in
the presence of the A1R antagonist CPT (1 M) in slices from
WT mice (Fig. 2B2). These results argue strongly that longlasting hypoxia causes modest loss of synaptic transmission but
that activation of A1Rs prevents any lasting impairment.
Similar results were quantified during and after experimental
hypoglycemia. Durations of 5, 10, and 30 min of hypoglycemia
caused rapid inhibition (partial inhibition with 5-min hypoglycemia, complete inhibition with longer durations) and a complete recovery of fEPSP amplitude in the hippocampal slices
from WT mice. A lasting, modest loss of synaptic transmission
was quantified in A1KO mice or in the presence of CPT in WT
mice for 30-min hypoglycemia (Fig. 3, A and B). These results
indicate that, as with hypoxia, hypoglycemia causes slight
irreversible suppression of synaptic transmission, but this impairment is typically prevented by the protective effect of
A1Rs.
Reduced glucose with hypoxia caused irreversible synaptic
loss. We also tested changes in synaptic transmission while
reducing glucose (from 11 to 3 mM) and removing oxygen. As
shown above, 10 min of experimental ischemia caused partial
but significant recovery after rapid inhibition of fEPSP amplitude in WT slices (Fig. 1A). However, after the same duration
(10 min) of reduced glucose with hypoxia, the fEPSP ampli-
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(Fig. 4B). A duration longer than 20 min of reduced glucose
with hypoxia caused irreversible loss of synaptic transmission
(Fig. 4A), similarly to experimental ischemia. Whereas glucose
did extend the window of recovery after hypoxia, the acute
protective effect of A1Rs was overcome or disabled by a
long-term (⬎15 min) exposure to reduced glucose with
hypoxia.
DISCUSSION

In this study we quantified synaptic transmission during and
after ischemia, hypoxia, or hypoglycemia of varying durations
in acute mouse hippocampal slices. We also quantified the
effects of genetic or pharmacological inactivation of A1Rs
during and after these metabolically stressful events. A1R
activation controlled the onset, rate, and magnitude of synaptic
inhibition during the loss of oxygen and/or glucose and significantly influenced the magnitude of synaptic recovery.
Functional effects of A1Rs during metabolic stress have
been reported in several lines of experiments in hippocampal
slices. Experimental ischemia with short duration (5–10 min) is

Fig. 2. Experimental hypoxia-induced field excitatory postsynaptic potential
(fEPSP) modulation. A, left: change in fEPSP amplitudes with 5-, 10-, or
30-min experimental hypoxia (no oxygen: N2 ⫹ 11 mM glucose) in hippocampal slices from wild-type (WT) mice. Averages and SE of fEPSP amplitudes
are shown at each time point (2 min). Right: summary of averages of fEPSP
amplitudes at 1–2 min before hypoxia (before), during hypoxia (hypoxia), and
15–20 min after hypoxia (recovery). NS, not significantly different (1-way
ANOVA with post hoc test). B1: effects of 10-min hypoxia (N2 ⫹ 11 mM
glucose) in slices from WT mice or adenosine A1 receptor knockout (A1KO)
mice. Data shown from WT mice are the same as 10-min hypoxia in A. **P ⬍
0.01 (unpaired t-test). B2: effects of 60-min hypoxia (N2 ⫹ 11 mM glucose) in
slices from WT mice, A1KO mice, or in the presence of 1 M 8-cyclopentyltheophylline (CPT) in WT mice (WT mice ⫹ CPT). A subset of data of WT
mice and A1KO mice are modified from a previous report (Johansson et al.
2001). *P ⬍ 0.05; **P ⬍ 0.01 (1-way ANOVA with post hoc test).

tude recovered completely (Fig. 4A; recovery of OGD,
46.2 ⫾ 10.7%, n ⫽ 19; 3 mM glucose with hypoxia, 100.3 ⫾
0.3%, n ⫽ 6; P ⬍ 0.05; unpaired t-test), suggesting that even
a reduced glucose level increases the recovery rate after a
hypoxic event. Fifteen minutes of reduced glucose with hypoxia also resulted in recovery of the fEPSP, but the recovery
amplitude was significantly smaller than after 10 min (Fig. 4A).
Recovery was not observed in hippocampal slices from A1KO
mice, indicating that the recovery of fEPSP amplitude after
reduced glucose with hypoxia is caused by activation of A1Rs

Fig. 3. Experimental hypoglycemia-induced field excitatory postsynaptic potential (fEPSP modulation. A, left: changes of fEPSP amplitudes with 5-, 10-,
or 30-min experimental hypoglycemia (no glucose: 95% oxygen ⫹ 0 mM
glucose) in hippocampal slices from wild-type (WT) mice. Averages and SE of
fEPSP amplitudes are shown at each time point (2 min). Right: summary of
averages of fEPSP amplitudes at 1–2 min before hypoglycemia (before),
during hypoglycemia (hypoglycemia), and 15–20 min after hypoglycemia
(recovery). Inhibition of fEPSP amplitude with 5-min hypoglycemia was
significantly lower than with 10- and 30-min hypoglycemia. NS, not significantly different; **P ⬍ 0.01 (1-way ANOVA with post hoc test). B: effects of
30-min hypoglycemia (O2 ⫹ 0 mM glucose) in slices from WT mice,
adenosine A1 receptor knockout (A1KO) mice, or in the presence of 1 M
8-cyclopentyltheophylline (CPT) in WT mice (WT mice ⫹ CPT). Data shown
from WT mice are the same as 30-min hypoglycemia in A. **P ⬍ 0.01 (1-way
ANOVA with post hoc test).
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Fig. 4. Experimental reduced glucose with hypoxia-induced field excitatory
postsynaptic potential (fEPSP) modulation. A, left: changes in fEPSP amplitudes with 10-, 15-, or 20-min reduced glucose with hypoxia (no oxygen: N2 ⫹
3 mM glucose) in hippocampal slices from wild-type (WT) mice. Averages
and SE of fEPSP amplitudes are shown at each time point (2 min). Right:
summary of averages of fEPSP amplitudes at 1–2 min before reduced glucose
with hypoxia (before), during reduced glucose with hypoxia, and 15–20 min
after reduced glucose with hypoxia (recovery). Recovery of fEPSP amplitude
was lost gradually with an increased duration of reduced glucose with hypoxia.
NS, not significantly different; *P ⬍ 0.05; **P ⬍ 0.01 (1-way ANOVA with
post hoc test). B: effects of 15-min reduced glucose with hypoxia in slices from
WT and adenosine A1 receptor knockout (A1KO) mice. Data shown from WT
mice are the same as 15-min N2 ⫹ 3 mM glucose in A. **P ⬍ 0.01 (unpaired
t-test).

reported to cause A1R-induced reversible fEPSP inhibition
(Fowler 1990; Frenguelli et al. 2007; Latini et al. 1999). A
longer exposure to ischemia (30 min) evokes irreversible loss
of synaptic activity even during extracellular adenosine release
(Frenguelli et al. 2007). Short-term exposure to hypoxia (5
min) is known to cause fEPSP inhibition through activation of
A1R (Dale et al. 2000; Fowler 1989). It has been reported that
⬎60 min of hypoxia induces a slight irreversible loss of the
fEPSP when A1Rs are inactivated (Johansson et al. 2001;
Sebastião et al. 2001). Hypoglycemia has been reported to
cause A1R-induced reversible fEPSP inhibition in hippocampal
slices (Zhu and Krnjević 1993). On the basis of these previous
reports, we compared the effects of A1R during these metabolic stresses using the same animal species and the same
recording system, and compared genetic and pharmacological
inactivation of A1Rs. We found a particular duration of ischemia (10 min) that caused partial but significant recovery of
fEPSP amplitude in the hippocampal slices (Fig. 1A). This
recovery was mediated by activation of A1R (Fig. 1B2). We
also found that a rise in extracellular glucose concentration
increased A1R-mediated recovery rate (Fig. 4). Our new finding shows that long-term exposure to hypoglycemia evoked a
small but significant irreversible depression of synaptic activity
with blockade of A1R (Fig. 3B), similarly to hypoxia (Fig.
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3B2). Previous work investigated the effects of A1R during
metabolic stresses typically using pharmacology, with the
exception of a long duration of hypoxia (Johansson et al.
2001). We examined all of these A1R effects by using A1KO
mice in the current study and confirmed our findings using
pharmacology.
Manipulating the duration of ischemia in hippocampal slices
revealed sequential changes to synaptic transmission with
varying levels of reversibility strongly influenced by A1Rs: 1)
a rapid direct inhibition, 2) a slower onset of A1R-independent
inhibition, 3) a transient reappearance of activity, and 4) an
irreversible loss of transmission. The initial reversible inhibition is a well-known phenomenon caused by A1Rs (Latini et al.
1999) that inhibit presynaptic voltage-dependent calcium channels (Gundlfinger et al. 2007; Wu and Saggau 1994) in glutamatergic nerve terminals (Rebola et al. 2005); the NOS-cGMP
pathway also appears to be involved (Pinto et al. 2016).
We found delayed synaptic depression occurring in tissue
lacking A1R. Although the exact mechanism remains unknown, it has been reported that in vitro ischemia causes
synaptic depression of fEPSPs by increasing calcium concentration in the presynaptic terminals (Jalini et al. 2016), which
might cause excessive release of glutamate. The increase of
glutamate release induces a transient reappearance of transmission during ischemia (Pugliese et al. 2003) and anoxic depolarization of pyramidal neurons (Madry et al. 2010). Because
activation of A1Rs inhibits calcium entry into axonal terminals,
this may be a protective effect, delaying but not preventing the
ischemia-induced synaptic impairment.
It has been reported that prolonged activation of A1R with
ischemia/hypoxia or applying a selective A1R agonist causes
synaptic depression of fEPSP in rat hippocampal slices (Chen
et al. 2014; Stockwell et al. 2016). There is no A1R-induced
synaptic depression recorded in our experiments, suggesting
that a species difference might be involved. In contrast, shortterm exposure to ischemia is known to cause chemical longterm potentiation after recovery from rapid depression of
synaptic activity (Ai and Baker 2006). It has been reported that
the plasticity is caused by activation of A2AR in rat hippocampus slices (Dias et al. 2013). In a few recordings, we observed
an increase of fEPSP amplitude after recovery from short-term
exposure to metabolic stresses. However, the amplitudes of
fEPSP before and after events were not significantly different
in all the tested types of short-term metabolic stresses (Figs.
1A, 2A, 3A and 4A).
Our method for experimental ischemia reproduced an acute
phase of ischemic stroke (Yenari and Han 2012). In this
condition, activation of A1R produced protection of neuronal
synaptic activity against 10-min ischemia (Fig. 1B2). However,
long-term exposure to ischemia (30 min) caused irreversible
synaptic loss even in slices from WT mice (Fig. 1A). Therefore, the effect of A1R against the acute phase of ischemic
stroke might be limited. Moreover, the effect of A1R during the
chronic phase of ischemic stroke is poor. The neuronal damage
after global ischemic events is not different between WT mice
and A1KO mice in vivo (Olsson et al. 2004). The role of
A1R-induced neurosynaptic protection in the acute phase of
ischemia should be investigated carefully in further studies.
Reduced glucose with hypoxia affected fEPSPs similarly to
ischemia, but the magnitude of recovery after 10 min of
treatment was increased significantly. This recovery was due to
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A1Rs, suggesting that the presence of an energy source in the
aCSF enhances the neuroprotective effects of these receptors.
Whereas 3 mM glucose is a physiological level in brain
(Abi-Saab et al. 2002; Hu and Wilson 1997; Shram et al. 1997;
Silver and Erecińska 1994), typically brain slices are recorded
in a higher glucose level (11 mM). Enhanced responses due to
higher glucose may be one reason why typical protocols use a
supraphysiological glucose concentration; for example, glucose concentration is often at least 10 mM in solutions used for
maintaining or recording from acute brain slices or slice
cultures. However, normal synaptic physiology and long-term
maintenance in vitro have been demonstrated with a physiological level of glucose using the present type of open, dualsuperfusion chamber (Kawamura et al. 2014) or a closed,
boxlike superfusion chamber (Tian and Baker 2002).
Both hypoxia and hypoglycemia caused rapid synaptic inhibition via A1Rs but contrasted with ischemia in the later
effects. Hypoglycemia caused a mild A1R-independent depression with no transient reappearance and no loss of transmission
even after 30 min of treatment; hypoxia caused a mild A1Rindependent depression with no transient reappearance and
only a small-magnitude irreversible loss even after 60 min of
treatment. However, an irreversible synaptic depression was
masked by the presence of A1R activation: the fEPSP did not
completely recover after hypoxia or hypoglycemia in the hippocampal slices from A1KO mice or in the presence of an A1R
antagonist in WT mice, clearly showing the involvement of
this receptor in synaptic recovery. The mechanisms of A1R
antagonist-induced synaptic depression are still undetermined.
It has been reported that inhibition of NMDA receptors causes
hypoxia-induced fEPSP recovery (Sebastião et al. 2001), suggesting that A1R-mediated NMDA receptor inhibition (de
Mendonça et al. 1995) might be involved in the recovery.
The source of extracellular adenosine during experimental
metabolic stress such as ischemia, hypoxia, or hypoglycemia is
still undetermined (Kawamura and Ruskin 2012). It has been
reported that knockout of CD73 does not prevent endogenous
adenosine-induced synaptic inhibition, suggesting that breakdown from AMP to adenosine with ecto-5=-nucleotidase is not
responsible for the increased extracellular adenosine and that
ATP release is not the source (Zhang et al. 2012). A study
using ATP and adenosine sensors showed ATP release during
ischemia, but its concentration was markedly lower than that of
adenosine (Frenguelli et al. 2007). Accordingly, it is thought
that metabolic stress causes direct release of adenosine in the
hippocampus, but the site of release remains unresolved. Certainly the equilibrative nucleoside transporter is thought to be
one of the mechanisms to transfer adenosine from intracellular
to extracellular space (Cunha et al. 1996; Lovatt et al. 2012).
However, a previous study reported that inhibitors of equilibrative nucleoside transporters did not reduce endogenous
adenosine-induced synaptic inhibition during ischemia or hypoxia (Zhang et al. 2012) and did not increase the concentration
of extracellular adenosine in ischemia (Frenguelli et al. 2007).
To elucidate the adenosine-releasing mechanism in the present
study, additional experiments will be needed.
In sum, we report functional effects of A1Rs across four
experimental metabolic stresses. Activation of A1Rs is essential to recover synaptic transmission after ischemia or after
reduced glucose with hypoxia, and thus receptor activation
might extend the time window for ischemia-induced irrevers-

ible synaptic loss thought to be caused by cell death. A1Rs also
prevented a moderate lasting synaptic depression caused by a
longer duration of hypoxia or hypoglycemia. Selective genetic
or pharmacological inactivation yielded similar functional effects. Altogether, activation of A1Rs has a protective role
against a range of metabolic stresses in brain, and receptor
activity can serve to protect synaptic transmission entirely
depending on the duration of a specific stress.
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